WebKeros Therapeutics Powered by TGF-β science, inspired by patients At Keros, our mission is to innovate therapies that have the potential to shift the treatment paradigm for people … Working at Keros Current Opportunities Benefits About Us. At Keros, our … Working at Keros Current Opportunities Benefits Open Menu Close Menu. … Keros’ lead small molecule product candidate, KER-047, is being developed … It’s more than science for science sake. Improving human health changes the … Keros Therapeutics 1050 Waltham Street, Suite 302 Lexington, MA 02421 +1 (617) … Gray currently serves on the boards of BioAtla, Inc., Sarepta Therapeutics, Inc., … Christopher Rovaldi has served as our Chief Operating Officer since February … ** Keros Therapeutics has exclusively licensed from The General Hospital … Web1 mrt. 2024 · Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering …

KROS - Keros Therapeutics, Inc. Stock Price and Quote - FINVIZ.com

WebAmendment and Restatement of Certificate of Incorporation . On April 13, 2024, Keros Therapeutics, Inc. (the “Company”) filed an amended and restated certificate of … Web21 dec. 2024 · 14 februari 2024 gen stephen whiting

Keros Therapeutics Inc - Company Profile and News

Web10 nov. 2024 · About Keros Therapeutics, Inc. Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering... WebLegal Name Keros Therapeutics, Inc. Stock Symbol NASDAQ:KROS. Company Type For Profit. Phone Number (617)513-8774. Keros is a clinical-stage biopharmaceutical … Web所属公司： Keros Therapeutics, Inc. 当前融资轮次：IPO上市. 成立日期：2015-01-01. 所属地：美国. 简介：Keros Therapeutics是一家美国血液系统及骨骼肌肉疾病治疗药物开发商，公司致力于治疗与TGF-β信号通路功能障碍相关的疾病。. 简介：Keros Therapeutics是一 … chris daily vhb